General Information of Drug (ID: DMK8F0H)

Drug Name
CS02
Indication
Disease Entry ICD 11 Status REF
Type 2 diabetes 5A11 Phase 2 [1]
Cross-matching ID
TTD ID
D7ULC1

References

1 ClinicalTrials.gov (NCT03317028) A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of CS02 Tablet in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone. U.S.National Institutes of Health.